Fermenta Biotech Ltd

Other Announcement

Fermenta Biotech Other Announcement

KMP Sumesh Gandhi sold a total of 3,900 equity shares in three separate market transactions on September 7, 8, and 9, 2026.

Value

₹0.20 Cr

PartnershipAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Fermenta Biotech Partnership

Fermenta Biotech Limited signed an exclusive licence agreement with VIT Vellore to commercialize Vitamin B12 fortification technology for fermented foods, enhancing its product portfolio.

From

Vellore Institute of Technology (VIT), Vellore

Promoter Selling

Fermenta Biotech Promoter Selling: ₹2.2 Cr

Director Prashant Nagre sold 44,000 shares of Fermenta Biotech Ltd via market sale. The transaction value is Rs.2.20 Crore.

Value

₹2.20 Cr

Promoter stake change

-0.15%

Earnings Call

Fermenta Biotech Investor Presentation: Key Takeaways

Q1FY27 revenue flat sequentially at INR 126.2 crore. Human nutrition volume grew 18% QoQ, offsetting animal nutrition weakness. EBITDA stood at INR 22.4 crore (17.7% margin).

Financial Results

Fermenta Biotech Q1 FY27 Results: Net Profit ₹9.5 Cr, Down 56.0% YoY

Fermenta Biotech Ltd reported revenue from operations of ₹121.8 Cr (-10.6% YoY) and net profit of ₹9.5 Cr (-56.0% YoY) for Q1 FY27.

Key figure

Net profit ₹9.5 Cr · -56.0% YoY